To validate these findings, the proportion of classical macrophages was examined via co-staining for M1 (CD80) and M2 (CD163) markers in a previous craniopharyngioma specimen, which revealed similar consistent results (Figure 6H). This evidence concerns the gene CD163 and craniopharyngioma.